Development and Validation of Nine Deprescribing Algorithms for Patients on Hemodialysis to Decrease Polypharmacy

BACKGROUND: Polypharmacy is ubiquitous in patients on hemodialysis (HD), and increases risk of adverse events, medication interactions, nonadherence, and mortality. Appropriately applied deprescribing can potentially minimize polypharmacy risks. Existing guidelines are unsuitable for nephrology clin...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Can J Kidney Health Dis
Principais autores: Lefebvre, Melissa J., Ng, Patrick C. K., Desjarlais, Arlene, McCann, Dennis, Waldvogel, Blair, Tonelli, Marcello, Garg, Amit X., Wilson, Jo-Anne, Beaulieu, Monica, Marin, Judith, Orsulak, Cali, Lloyd, Anita, McIntyre, Caitlin, Feldberg, Jordanne, Bohm, Clara, Battistella, Marisa
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2020
Assuntos:
Original Clinical Research Quantitative
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7605037/
https://ncbi.nlm.nih.gov/pubmed/33194213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2054358120968674
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados